The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Increased Cardiac Death or Decreased Motor Vehicle Accidents?

To the Editor: It was with great interest that we read the article by Madelyn S. Gould, Ph.D., M.P.H., et al. (1), published in the September 2009 issue of the Journal. In a case-control study, the authors arrived at the conclusion that there may be an association between the use of prescribed stimulants and an increased risk of sudden cardiac death. The comparison they used to establish this association was a group of youths who perished in motor vehicle accidents. The authors justified this decision by citing evidence that stimulant users were not likely to be overrepresented within this group.

In finding a higher percentage of stimulant users in the cardiac death group compared with the percentage of stimulant users in the motor vehicle victim group, Dr. Gould et al. made the interpretation that stimulants are likely to increase the risk of cardiac death. However, there is an alternative interpretation that deserves consideration and that, perhaps, has more support in the recent literature. There is a burgeoning interest among clinicians and researchers regarding the effect of attention deficit hyperactivity disorder (ADHD) on driving behavior. The evidence is strong that ADHD is associated with an increased risk of motor vehicle accidents (2) and that stimulants significantly attenuate this risk (2, 3). Thus, it may not be that stimulants were overrepresented in the cardiac death group. It may just appear so because they actually lower the risk of motor vehicle accidents in adolescents and young adults with ADHD and therefore were underrepresented in the comparator group.

This study has attracted significant media attention and has already affected our clinical practice in the short time since its publication. We hope that it will not result in hasty conclusions, driving (quite literally) patients toward the risks of untreated ADHD out of a possibly unfounded fear of treatment. In our view, the tiny risk of cardiac complications from stimulant treatment of a high-risk condition such as ADHD is more than outweighed by the benefits accrued in fewer motor vehicle accidents.

Dr. Blume is the recipient of an American Psychiatric Institute for Research and Education/Janssen Research Scholar Fellowship; Dr. Rostain has served as a consultant to Ortho-McNeil and Shire; he has also served on the speaker's bureau of Eli Lilly, Ortho-McNeil, and Shire.

This letter was accepted for publication in October 2009.

References

1 Gould MS , Walsh BT , Munfakh JL , Kleinman M , Duan N , Olfson M , Greenhill L , Cooper T : Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166:992–1001 LinkGoogle Scholar

2 Barkley RA , Cox D : A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res 2007; 38:113–128 Crossref, MedlineGoogle Scholar

3 Verster JC , Bekker EM , de Roos M , Minova A , Eijken EJ , Kooij JJ , Buitelaar JK , Kenemans JL , Verbaten MN , Olivier B , Volkerts ER : Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial. J Psychopharmacol 2008; 22:230–237 Crossref, MedlineGoogle Scholar